Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107976
Filing Date
2025-11-07
Accepted
2025-11-06 20:02:44
Documents
79
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20250930x10q.htm   iXBRL 10-Q 2130276
2 EX-31.1 ntra-20250930xex31d1.htm EX-31.1 13737
3 EX-31.2 ntra-20250930xex31d2.htm EX-31.2 14821
4 EX-32.1 ntra-20250930xex32d1.htm EX-32.1 10305
5 EX-32.2 ntra-20250930xex32d2.htm EX-32.2 10557
  Complete submission text file 0001104659-25-107976.txt   9489142

Data Files

Seq Description Document Type Size
6 EX-101.SCH ntra-20250930.xsd EX-101.SCH 59731
7 EX-101.CAL ntra-20250930_cal.xml EX-101.CAL 59831
8 EX-101.DEF ntra-20250930_def.xml EX-101.DEF 244639
9 EX-101.LAB ntra-20250930_lab.xml EX-101.LAB 520924
10 EX-101.PRE ntra-20250930_pre.xml EX-101.PRE 390377
82 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20250930x10q_htm.xml XML 1886935
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 251460092
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)